Litcius/Paper detail

Identification of key microRNAs as predictive biomarkers of Nilotinib response in chronic myeloid leukemia: a sub-analysis of the ENESTxtnd clinical trial

Ryan Yen, Sarah Grasedieck, Andrew Wu, Hanyang Lin, Jiechuang Su, Katharina Rothe, Helen Nakamoto, Donna L. Forrest, Connie J. Eaves, Xiaoyan Jiang

2022Leukemia14 citationsDOI

Topics & Concepts

NilotinibMedicineOncologyMyeloid leukemiaInternal medicineHazard ratiomicroRNAProportional hazards modelLeukemiaMyeloidImmunologyImatinibBiologyConfidence intervalGeneBiochemistryChronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia ResearchMyeloproliferative Neoplasms: Diagnosis and Treatment